Upadhye Cwik LLP

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Cases23

Challenger50%

Patent Owner50%

NPE50%

Practice Areas

BiotechTransport., E-Comm.Reexam/Aband.

Top Attorneys

Patrick J. CoyneNeal S. CohenPeter Kinsella

Elite Ratings

DCTPTABCAFC

Ratings

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Experience

Grade

Trend

DCT

PTAB

CAFC

Analytics

Lawyers

Cases

Ratings Trends

Practice Areas

Recent Dockets

Entered	Case	Description
01/09/25	Nivagen Pharmaceuticals Inc v. Amneal Pharmaceuticals Inc 1:24-CV-00846 ( D. DE )	SO ORDERED, re [96] STIPULATION TO EXTEND TIME for Defendants to file their answering brief in opposition to Plaintiff Nivagen Pharmaceuticals, Inc.s Motion to Dismiss and Motion to Strike to January 28, 2025, and to extend the deadline for Plaintiff to file its reply br filed by Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals, Inc., Amneal EU Ltd., Amneal Pharmaceuticals Pvt. Ltd. Signed by Judge Gregory B. Williams on 1/9/2025. (lnb) (Entered: 01/09/2025) SO ORDERED, re [96] STIPULATION TO EXTEND TIME for Defendants to file their answering brief in opposition to Plaintiff Nivagen Pharmaceuticals, Inc.s Motion to Dismiss and Motion to Strike to January 28, 2025, and to extend the deadline for Plaintiff to file its reply br filed by Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals, Inc., Amneal EU Ltd., Amneal Pharmaceuticals Pvt. Ltd. Signed by Judge Gregory B. Williams on 1/9/2025. (lnb) (Entered: 01/09/2025)
12/20/24	Acadia Pharmaceuticals Inc v. Aurobindo Pharma Ltd 1:22-CV-01387 ( D. DE )	REDACTED VERSION of [112] Memorandum Opinion by ACADIA Pharmaceuticals Inc.. (Guzzo, Jennifer) (Entered: 12/20/2024)
12/18/24	Astellas Pharma Inc v. Sandoz Inc 1:20-CV-01589 ( D. DE )	Pro Hac Vice Attorney Michael DelRossi for Astellas Ireland Co., Ltd.,Michael DelRossi for Astellas Pharma Global Development, Inc.,Michael DelRossi for Astellas Pharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (scs) (Entered: 12/18/2024)
11/19/24	Jazz Pharmaceuticals Research Uk Ltd v. Teva Pharmaceuticals Inc 2:23-CV-00018 ( D. NJ )	CLERK'S QUALITY CONTROL MESSAGE - Case Closed in Error, Please Disregard (ld, ) (Entered: 11/19/2024)
11/01/24	Harmony Biosciences LLC v. Lupin Ltd 1:23-CV-01286 ( D. DE )	PROPOSED CONSENT JUDGMENT as to Novugen Pharma Sdn. Bhd. and Novugen Pharma (USA) LLC by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC. (Tigan, Jeremy) (Entered: 11/01/2024)
10/02/24	Nivagen Inc v. Sun Pharmaceuticals Industries Inc 2:24-CV-00036 ( E.D. TX )	PROTECTIVE ORDER (Motion(s) [40] terminated). Signed by Magistrate Judge Roy S. Payne on 10/2/2024. (NKL) (Entered: 10/02/2024)
08/20/24	Pfizer Inc v. Sinotherapeutics Inc 1:21-CV-01427 ( D. DE )	Letter to The Honorable Gregory B. Williams from Megan E. Dellinger regarding parties' joint technology tutorial. (Dellinger, Megan) (Entered: 08/20/2024)
05/07/24	Acadia Pharmaceuticals Inc v. Aurobindo Pharma Ltd 1:20-CV-00985 ( D. DE )	Report to the Commissioner of Patents and Trademarks. (ntl) (Entered: 05/07/2024)
05/07/24	Acadia Pharmaceuticals Inc v. Aurobindo Pharma Ltd 1:20-CV-00985 ( D. DE )	CASE CLOSED (ntl) (Entered: 05/07/2024)
05/01/24	Harmony Biosciences LLC v. Aet Pharma US Inc 1:23-CV-01340 ( D. DE )	CORRECTING ENTRY: D.I. 48 has been deleted from the docket. All filings are to be made in the lead case (C.A. No. 23-1286) only. (ceg) (Entered: 05/01/2024)